Extracellular Vesicle–Based Biohybrid Enabling Synergistic Anti‐Oxidative Stress and Anti‐Inflammation for Targeted Therapy of Acute Kidney Injury
Source abstract
Abstract
Abstract Acute kidney injury (AKI) presents a significant clinical challenge, driven by oxidative stress and inflammatory responses. To address these pathological factors, a biohybrid nanoplatform, ESAK1, is developed by integrating a gold cluster artificial enzyme (AU), an extracellular vesicle obtained from genetically engineered renal tubular epithelial cell (tecEV), and a kidney injury‐targeting peptide (ktPep) via a bio‐orthogonal SnoopCatcher‐SnoopTag system derived from Streptococcus pneumoniae adhesins. Upon intravenous administration to mice with AKI, ESAK1 preferentially accumulates in injured renal tissues through ktPep‐mediated targeting. Subsequently, the AU component, exhibiting superior superoxide dismutase‐ and catalase‐like activities, scavenges excess reactive oxygen species (ROS) in situ, alleviating oxidative stress and simultaneously protecting the tecEV from ROS‐induced damage. Consequently, the tecEV exerts potent anti‐inflammatory effects, acting synergistically with oxidative stress neutralization to enhance the therapeutic efficacy. This dual‐action mechanism facilitates the activation of endogenous repair mechanisms, promoting kidney recovery, as evidenced by significantly reduced levels of serum creatinine and urea, diminished renal histopathological damage, decreased inflammatory cytokines, and enhanced expression of repair‐associated proteins. By integrating targeted delivery, anti‐oxidant defense, and anti‐inflammatory properties into a single platform, ESAK1 offers a promising multi‐faceted approach for advanced kidney‐protective therapies and even broader inflammatory diseases.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Acute Kidney Injury Research · Infectious Aortic and Vascular Conditions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Jiangxi Provincial Key Laboratory of Urinary System Diseases Department of Urology The First Affiliated Hospital Jiangxi Medical College Nanchang University Nanchang Jiangxi 330006 China
Postdoctoral Innovation Practice Base The First Affiliated Hospital Jiangxi Medical College Nanchang University Nanchang 330006 P. R. China
State Key Laboratory of Food Science and Resources Nanchang University Nanchang 330047 China
Funding
National Natural Science Foundation of China · Natural Science Foundation of Jiangxi Province
References (84)
Show source-provided references
1. 10.1016/S0140-6736(24)02385-710.1016/S0140-6736(24)02385-7 ↗
2. 10.1038/s41572-021-00284-z10.1038/s41572-021-00284-z ↗
3. 10.3390/ijms2012301110.3390/ijms20123011 ↗
4. 10.1002/adfm.20240989210.1002/adfm.202409892 ↗
5. 10.1038/ki.2012.42710.1038/ki.2012.427 ↗
6. 10.1186/cc1145410.1186/cc11454 ↗
7. 10.1016/j.tcb.2023.01.00210.1016/j.tcb.2023.01.002 ↗
8. 10.33549/physiolres.93512910.33549/physiolres.935129 ↗
9. 10.1038/s41536-022-00268-x10.1038/s41536-022-00268-x ↗
10. 10.1111/jcmm.1574110.1111/jcmm.15741 ↗
11. 10.1681/ASN.201612127810.1681/ASN.2016121278 ↗
12. 10.1016/j.biomaterials.2025.12316510.1016/j.biomaterials.2025.123165 ↗
13. 10.1016/j.bbrc.2021.03.05710.1016/j.bbrc.2021.03.057 ↗
14. 10.1155/2022/355361710.1155/2022/3553617 ↗
15. 10.3389/fncel.2020.0016010.3389/fncel.2020.00160 ↗
16. 10.1007/s00204-024-03696-410.1007/s00204-024-03696-4 ↗
17. 10.1021/acs.chemrev.8b0067210.1021/acs.chemrev.8b00672 ↗
18. 10.3389/fchem.2020.0021910.3389/fchem.2020.00219 ↗
19. 10.3389/fbioe.2022.92021310.3389/fbioe.2022.920213 ↗
20. 10.1002/adfm.20240477410.1002/adfm.202404774 ↗
21. 10.1126/sciadv.adh782810.1126/sciadv.adh7828 ↗
22. 10.1002/adhm.20230145010.1002/adhm.202301450 ↗
23. 10.1021/acs.jpclett.2c0107110.1021/acs.jpclett.2c01071 ↗
24. 10.1016/j.foodchem.2023.13796310.1016/j.foodchem.2023.137963 ↗
25. 10.1038/s41392-023-01382-y10.1038/s41392-023-01382-y ↗
26. 10.1039/D2NH00070A10.1039/D2NH00070A ↗
27. 10.1021/jp304537m10.1021/jp304537m ↗
28. 10.1073/pnas.151921411310.1073/pnas.1519214113 ↗
29. 10.3390/ijms2009212910.3390/ijms20092129 ↗
30. 10.1681/ASN.202011156110.1681/ASN.2020111561 ↗
31. 10.1038/ncomms534810.1038/ncomms5348 ↗
32. 10.1093/nar/gks119310.1093/nar/gks1193 ↗
33. 10.7150/ijbs.10433510.7150/ijbs.104335 ↗
34. 10.1681/ASN.202010145510.1681/ASN.2020101455 ↗
35. 10.1038/nrc216710.1038/nrc2167 ↗
36. 10.3390/ijms2104152710.3390/ijms21041527 ↗
37. 10.1038/sj.ki.500231210.1038/sj.ki.5002312 ↗
38. 10.1002/jcp.2016910.1002/jcp.20169 ↗
39. 10.1159/00052684210.1159/000526842 ↗
40. 10.3390/ijms2307379210.3390/ijms23073792 ↗
41. 10.1016/j.apsb.2020.12.01410.1016/j.apsb.2020.12.014 ↗
42. 10.1016/j.phymed.2021.15346610.1016/j.phymed.2021.153466 ↗
43. 10.3390/cells1004090810.3390/cells10040908 ↗
44. 10.1002/jcp.2455410.1002/jcp.24554 ↗
45. 10.1096/fj.202302596R10.1096/fj.202302596R ↗
46. 10.4103/1673-5374.34646610.4103/1673-5374.346466 ↗
47. 10.1016/j.cbi.2019.10873910.1016/j.cbi.2019.108739 ↗
48. 10.1002/adma.20231042110.1002/adma.202310421 ↗
49. 10.1016/j.ccr.2013.07.00810.1016/j.ccr.2013.07.008 ↗
50. 10.1002/path.166510.1002/path.1665 ↗
51. 10.1021/acs.analchem.1c0374810.1021/acs.analchem.1c03748 ↗
52. 10.1038/s41467-021-21714-210.1038/s41467-021-21714-2 ↗
53. 10.1016/j.redox.2017.02.00110.1016/j.redox.2017.02.001 ↗
54. 10.1016/j.chemosphere.2022.13566210.1016/j.chemosphere.2022.135662 ↗
55. 10.1038/nmeth.147510.1038/nmeth.1475 ↗
56. 10.1002/jev2.1207210.1002/jev2.12072 ↗
57. 10.1021/acsnano.4c0577310.1021/acsnano.4c05773 ↗
58. 10.1016/j.bioactmat.2022.02.01910.1016/j.bioactmat.2022.02.019 ↗
59. 10.1038/nmat471810.1038/nmat4718 ↗
60. 10.1080/20013078.2020.180906410.1080/20013078.2020.1809064 ↗
61. 10.1016/j.tibs.2004.11.00910.1016/j.tibs.2004.11.009 ↗
62. 10.1208/s12248-015-9857-y10.1208/s12248-015-9857-y ↗
63. 10.1681/ASN.201408074110.1681/ASN.2014080741 ↗
64. 10.1155/2017/852364910.1155/2017/8523649 ↗
65. 10.1152/physiol.00046.201410.1152/physiol.00046.2014 ↗
66. 10.1681/ASN.200906061510.1681/ASN.2009060615 ↗
67. 10.1053/j.ajkd.2014.05.02410.1053/j.ajkd.2014.05.024 ↗
68. 10.1038/ki.2008.30410.1038/ki.2008.304 ↗
69. 10.1007/s00281-011-0280-x10.1007/s00281-011-0280-x ↗
70. 10.3390/v1308155310.3390/v13081553 ↗
71. 10.1016/j.molimm.2015.07.01610.1016/j.molimm.2015.07.016 ↗
72. 10.1007/s00204-014-1264-010.1007/s00204-014-1264-0 ↗
73. 10.1042/bj334048910.1042/bj3340489 ↗
74. 10.1016/j.cyto.2016.07.00510.1016/j.cyto.2016.07.005 ↗
75. 10.1182/blood-2016-07-73055610.1182/blood-2016-07-730556 ↗
76. 10.1111/bph.1547610.1111/bph.15476 ↗
77. 10.1016/j.jprot.2023.10482210.1016/j.jprot.2023.104822 ↗
78. 10.1016/j.phrs.2021.10596210.1016/j.phrs.2021.105962 ↗
79. 10.1016/j.thromres.2022.06.00210.1016/j.thromres.2022.06.002 ↗
80. 10.3389/fcell.2020.60152110.3389/fcell.2020.601521 ↗
81. 10.1016/j.tibs.2019.10.00410.1016/j.tibs.2019.10.004 ↗
82. 10.1007/s00467-011-1785-110.1007/s00467-011-1785-1 ↗
83. 10.1016/j.matbio.2013.08.00410.1016/j.matbio.2013.08.004 ↗
84. 10.1002/jev2.1229010.1002/jev2.12290 ↗